易事特漲停 稱有計劃切入第三代半導體功率模組研發製造產業
格隆匯7月16日丨易事特(300376.SH)拉昇漲20%漲停,報9.44元,股價創去年11月以來新高,市值218億元。公司在7月14日披露的調研活動信息中表示,公司承擔了2019年廣東省科技廳第三代半導體重大專項中SiC功率器件應用技術研發及產業化課題,將在第三代半導體領域持續深入的進行研發和應用工作,將第三代半導體氮化鎵、碳化硅功率器件對現有產品的功率器件進行替代升級,實現更好效能同時也能減少進口依賴。公司也有計劃新增第三代半導體模組生產線切入第三代半導體功率模組研發製造產業,為原有高端電子裝備產品升級換代提供核心支撐。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.